Introduction: Determination of exercise oscillatory ventilation (EOV) is subjective, and the interreviewer agreement has not been reported. The purposes of this study were, among patients with heart failure (HF), as follows: 1) to determine the interreviewer agreement for EOV and 2) to describe a novel, objective, and quantifiable measure of EOV. Methods: This was a secondary analysis of the HEART Camp: Promoting Adherence to Exercise in Patients with Heart Failure study. EOV was determined through a blinded review by six individuals on the basis of their interpretation of the EOV literature. Interreviewer agreement was assessed using Fleiss kappa (J). Final determination of EOV was based on agreement by four of the six reviewers. A new measure (ventilation dispersion index; VDI) was calculated for each test, and its ability to predict EOV was assessed with the receiver operator characteristics curve. Results: Among 243 patients with HF (age, 60 T 12 yr; 45% women), the interreviewer agreement for EOV was fair (J = 0.303) with 10-s discrete data averages and significantly better, but only moderate (J = 0.429) with 30-s rolling data averages. Prevalence rates of positive and indeterminate EOVs were 18% and 30% with the 10-s discrete averages and 14% and 13% with the 30-s rolling averages, respectively. VDI was strongly associated with EOV, with areas under the receiver operator characteristics curve of 0.852 to 0.890. Conclusions: Interreviewer agreement for EOV in patients with HF is fair to moderate, which can negatively affect risk stratification. VDI has strong predictive validity with EOV; as such, it might be a useful measure of prognosis in patients with HF.
A cardiopulmonary exercise test (CPET) is performed in patients with heart failure (HF) to quantify exercise capacity, stratify risk, and estimate prognosis (1) (2) (3) (4) . Since the seminal study by Mancini and colleagues (5) in which they showed the prognostic significance of low peak oxygen uptake (V O 2 ) in patients with compensated HF awaiting heart transplant, several other measures from the CPET have been shown to be related to prognosis in these patients (1, 2, 4, 6) . Among them, exercise oscillatory ventilation (EOV) is relatively new with increasing scientific interest over the past two decades (7) . EOV is an oscillatory pattern of ventilation during exercise that has been associated with worse prognosis in patients with HF (1, 4, (6) (7) (8) (9) (10) (11) (12) (13) . The mechanisms resulting in EOV are not clear but may be related to circulatory delay, increased chemosensitivity, pulmonary congestion, or ergoreflex signaling (14) .
The reported prevalence of EOV in patients with compensated HF has varied from 7% to 51% (7) . This is likely due to heterogeneity (e.g., disease severity, functional capacity) between study cohorts (7, 12) as well as the subjectivity and varying methods (e.g., criteria, data averaging) used to identify EOV (9, 12, 15) . Several criteria sets that are based on the amplitude of oscillations and the prevalence during exercise have been proposed to identify EOV (4, 10, 11, 13, 16, 17) . As described by Cornelis and colleagues (18) , the basis for these criteria is unclear and the subsequent interpretation by scientists is often ambiguous. Although EOV has been associated with prognosis in several studies of patients with HF (7), the absence of a gold standard method for identifying EOV and the lack of data on the reliability of determining EOV may have hampered widespread clinical adoption (12, 15) . The purposes of this study were, among patients with compensated HF, as follows: 1) to determine the interreviewer agreement for the determination of EOV and 2) to describe a novel, objective, and quantifiable measure of EOV. We hypothesized that this quantifiable measure would be positively related to the presence of EOV.
METHODS
Study overview. This was a secondary analysis of data from the HEART Camp: Promoting Adherence to Exercise in Patients with Heart Failure study. HEART Camp was a randomized, controlled trial in which the effect of a cognitivebehavioral intervention on long-term adherence to exercise training among patients with HF was evaluated. Details of the study design have been published (19) . An overview relevant to the present analysis is provided here. Patients 19 yr or older with a physician diagnosis of compensated stage C HF were enrolled from Bryan Health (Lincoln, NE) and Henry Ford Hospital (Detroit, MI) between December 2012 and June 2015. Eligible patients included those with either reduced or preserved ejection fraction and prescribed guidelinebased pharmacological therapy for at least 30 d before enrollment (19) . Exclusion criteria included unstable angina, myocardial infarction, coronary artery bypass graft surgery, or pacemaker implant within 6 wk of enrollment; regular participation in aerobic exercise 3 dIwk j1 within 8 wk of enrollment; and physical limitations or contraindications to aerobic and resistance exercise training (19) . The HEART Camp study was approved by the institutional review boards at the University of Nebraska (approval no. 608-11-FB) and Henry Ford Health System (approval no. 7424). Informed consent was obtained from all patients before study enrollment.
All patients completed a sign or symptom-limited maximal CPET before randomization. Tests were performed on the basis of guidelines published by the American Heart Association (20) . Patients were instructed to take their medications as prescribed. Treadmill was the preferred testing mode using a low-level protocol that starts at approximately 2 metabolic equivalents (METs) of task with increases of 1 MET every 2 min; however, alternate modes or protocols could be considered as indicated for select patients. Respiratory gasses were analyzed using a metabolic cart from MGC Diagnostics (Ultima; Minneapolis, MN) at both institutions. The gas and flow analyzers were calibrated immediately before each test on the basis of the manufacture's recommendations. Quality assurance testing (21) was performed by exercise testing laboratories at both institutions at the start of the study and every 6 months until exercise testing for the study was completed.
Quality assurance and subject CPET data were analyzed by a centralized core laboratory at Henry Ford Hospital, which was staffed by individuals not otherwise involved with the HEART Camp study. Peak exercise gas exchange measures were identified as the highest value during the final minute of exercise or the first interval in recovery on the basis of data averaged in discrete 20-s intervals. Microsoft Excel (Redmond, WA) was used to calculate the slope of the change in minute ventilation (V E ) to the change in carbon dioxide produced (V CO 2 ; $V E /$V CO 2 slope) via least-squares linear regression, which included all exercise data averaged in discrete 20-s intervals. Percent predicted maximal V O 2 was calculated on the basis of equations by Wasserman et al. (22) Assessment of EOV. The presence of EOV was assessed through a blinded review by six of the authors (C.B., J.E., J.M., P.C., B.V., and S.K.). Each of these individuals is experienced with CPET conduct and analysis and was asked to base his determination of EOV on his interpretation of the EOV literature. The intent was to provide a real-world evaluation of EOV interpretation. Recommendations from Kremser et al. (16) , Leite et al. (10) , and Guazzi et al. (4) represented the basis of these interpretations. Reviewers were asked to identify whether a test was positive, negative, or indeterminate for EOV. The final determination of EOV (positive or negative) for a given test required agreement by four of the six reviewers; otherwise, it was considered indeterminate.
Reviewers were provided tabular data averaged in discrete 30-s intervals and a graph of exercise time (x-axis) versus V E (y-axis) for each test, which was created using Microsoft Excel. To assist reviewers with their determination of EOV, graphs were printed in a large format (17. An objective and quantifiable measure of EOV. Given the subjective nature by which EOV is currently determined, we developed an objective and quantifiable measure of EOV using the calculations shown hereinafter. These calculations were limited to the exercise data (excluding the initial 60 s of exercise) and were based on rolling 30-s interval data. The intent was to quantify the combination of amplitude and frequency of ventilatory oscillations during exercise. First, the mean V E representing 30 s before and after each data interval was calculated. Second, ''V E dispersion'' was calculated for each data interval as the absolute difference between the V E at a given interval and the mean V E around (T30 s) that interval. Third, the total V E dispersion area (shown graphically in Fig. 1 ) was determined by calculating the area under the curve of exercise time versus the V E dispersion on the basis of the trapezoidal rule using equation 1. Finally, because the total V E dispersion area would be proportional to exercise test duration, we divided the total V E dispersion area by test duration in minutes and refer to this as the ''ventilation dispersion index'' (VDI).
where dV E is the absolute difference between the V E and the mean V E (T30 s) at a given interval, T is the exercise time in seconds, and i is the data interval starting at 70 s of exercise (i = 0) through the second to last exercise interval (i = N j 1). Statistical analysis. interreviewer agreement for the determination of EOV was assessed using Fleiss kappa (J) (23) . The ability of VDI to predict EOV was assessed using the area under the receiver operator characteristic curve (AUC). The VDI value corresponding to the optimal combination of sensitivity and specificity to predict EOV from the receiver operator characteristic curve data was identified via Youden's index (24) . Continuous data were compared using Student's t-test or Mann-Whitney U test for normally and nonnormally distributed data, respectively. Categorical data were compared using chi-square. The two-sided alpha level was G0.05. Unless noted otherwise, continuous data are reported as mean T SD. IBM SPSS version 24 (IBM, Somers, NY) with the advanced statistics module was used for all analyses.
RESULTS
Among 246 patients who performed a CPET for enrollment into the HEART Camp study, 243 had complete CPET data for the present analysis. Characteristics of this cohort are shown in Table 1 . All but two of the tests were completed on a treadmill. These two alternate modes were a leg Unless noted otherwise, data are mean T SD or n (% of group). ACE, angiotensin-converting enzyme inhibitor; ARB, angiotensin receptor blocker; BNP, brain natriuretic peptide.
(cycle) ergometer and a semirecumbent stepper. The protocol for each started at approximately 2 METs, with increases of 2 METs every 3 min. Among the patients tested on a treadmill, 92% performed the study-recommended low-level protocol (~1-MET increment every 2 min). The remaining patients were tested using another low-level protocol (2-to 3-MET increment every 3 min). Mean exercise duration for all patients was 9.2 T 3.5 min. In 83% of the patients, the primary reason tests were stopped was general fatigue (n = 121) or shortness of breath (n = 81). As shown in Table 2 , on the basis of the Landis and Koch (25) interpretation, the interreviewer agreement for EOV was moderate (i.e., J = 0.41-0.60) and fair (i.e., J = 0.21-0.40) when data were graphed using 30-s rolling intervals (J = 0.429) and 10-s discrete intervals (J = 0.303), respectively. On the basis of the 95% confidence intervals for J that do not overlap, the agreement was significantly better when data were graphed using 30-s rolling intervals compared with the 10-s discrete intervals. In addition, the final determination of EOV on the basis of agreement by four of the six reviewers was indeterminate in less than half as many tests when data were graphed using 30-s rolling intervals (n = 32) compared with the 10-s discrete intervals (n = 73).
Because the interreviewer agreement was significantly better with data averaged using 30-s rolling intervals, we chose to limit the results for VDI to the same data averaging method. As shown in Figure 2 , the distribution of VDI was positively skewed. Log transformation of VDI resulted in a nearly normal distribution. There was a strong association between VDI and the final EOV as determined through agreement by four of the six reviewers (Table 3) . This was true regardless of whether the indeterminate EOV values were excluded (AUC = 0.890) or assumed to be positive (AUC = 0.852) or negative (AUC = 0.860). On the basis of the receiver operator characteristics curve data, a VDI of Q0.924
represented the optimal balance between sensitivity and specificity to identify EOV. Patient characteristics less than and greater than a VDI of 0.924 are shown in Supplement Table 1 (see Table, Supplemental Digital Content 2, Patient characteristics by VDI cut-point, http://links.lww.com/MSS/ B35). Compared with a VDI of G0.924, a VDI of Q0.924 was associated with a significantly larger proportion of men and tests that were EOV positive.
The interreviewer agreement and the receiver operator characteristics curve analyses were repeated in select subgroups ( Table 4 ). The interreviewer agreement varied within subgroups by ejection fraction and peak V O 2 . EOV was more prevalent among men compared with women and among patients with an ejection fraction of e40% compared with 940%. No meaningful variations were noted for the relationship between VDI and EOV as shown by the AUC.
DISCUSSION
Using standardized data graphing methods, we showed that the current interpretation of criteria sets for EOV by CPET experts results in fair to moderate interreviewer agreement in patients with HF. This agreement was significantly better and resulted in fewer indeterminate EOV values when data were averaged using 30-s rolling intervals (J = 0.429) versus 10-s discrete intervals (J = 0.303). We also evaluated a novel and objective mathematical model that quantifies EOV, the VDI. In support of our hypothesis, the VDI was strongly associated with the presence of EOV as determined by at least four of six CPET experts. The sensitivity and specificity to predict EOV with a VDI of Q0.924 was 89% and 80%, respectively (Table 3) . A template to calculate the VDI is provided (see Document, Supplemental Digital Content 3, VDI calculator, http://links.lww.com/MSS/B36).
Among available measures from the CPET, interest in EOV is relatively recent. There currently are four distinct sets of criteria for EOV with variations developed from these (15) . There have been at least 20 studies of patients with ambulatory HF in which the association between EOV and clinical outcomes was evaluated (6) (7) (8) . As discussed by Cornelis and colleagues (15) , the criteria set used to determine EOV are typically cited, but the methodological details have been sparse, making replication difficult. Although EOV has been consistently shown to predict risk in patients with HF (6-8), the incomplete description of methods and lack of consistent methodology to determine EOV in previous studies have hindered its broader clinical application (12, 15) . There are two studies in which the methods used to evaluate EOV were assessed. Francis et al. (26) showed that the amplitude of ventilatory oscillations during exercise is 35% smaller when data are averaged using 30-s intervals compared with 10-s intervals. This difference is consistent with the present findings in which the prevalence of positive, negative, and indeterminate EOV values differed between data averaging methods. In another study, Ingle and colleagues (9) evaluated the effect of two different criteria on the identification of EOV evaluated by two reviewers. Among 240 patients, EOV was identified in 47 patients on the basis of both criteria sets and another 40 patients were identified by one, but not both criteria sets (12) . Together, these results highlight the importance of providing methodological details sufficient for replication and the need for standardization.
A few investigators have reported mathematical methods to describe aspects of EOV. First among these was Francis and colleagues (27) , who reported a method to quantify the relative amplitude of ventilatory oscillation, which was later modified by Dall'Ago and colleagues (28) . Although this measure has been used as a study outcome (27) (28) (29) (30) , it has not been developed to identify EOV or quantify total ventilatory dispersion during exercise. Olson and Johnson (31) reported several mathematical methods to quantify the amplitude and periodicity of ventilatory oscillations. They concluded that their methods might be combined in an algorithm to identify EOV. Interestingly, in the Periodic Breathing during Exercise Study, Guazzi and colleagues (8) analyzed tests for EOV by a ''rapid manual calculation'' but did not provide details of this method. Finally, Cornelis and colleagues (18) may be the only investigators who have reported an automated system to detect EOV, the VOdEX-tool. Although promising, it is proof of concept and has not been tested.
Limitations. The present study is not without limitations. First, reviewers were not trained to assess EOV on the basis of a single set of criteria; therefore, our results do not provide insight into the interreviewer agreement for any particular EOV criteria. However, our results do shed light on the current state of EOV determination in clinical practice among patients with HF. It is unknown whether these results apply to other patient groups. Second, we did not assess the reliability of a single or multireviewer methodology to determine EOV. This remains an opportunity for future study. Third, EOV was indeterminate in 13% (using 30-s rolling intervals) and 30% (using 10-s discrete intervals) of our tests. This was a result of allowing reviewers to identify a test as indeterminate and requiring agreement among the majority (four of six) of the reviewers. This might better reflect realworld situations in which CPET data in patients with HF are often noisy and reviewer confidence in the determination of EOV is low. Interestingly, we are not aware of any studies in which indeterminate EOV values were reported. On the basis of the available studies, an indeterminate EOV does not assist with prognosis estimates. Finally, patients in the present study were enrolled into an exercise training trial. As a result, they may have been healthier and thus had a lower prevalence of EOV compared with the typical patient with stable HF who might be referred for a CPET.
CONCLUSIONS
Interreviewer agreement for EOV is fair to moderate in patients with HF and is better when using a 30-s rolling (vs 10-s discrete) interval data averaging method. This level of agreement could negatively affect risk stratification. VDI is a quantifiable method that shows strong predictive validity with EOV as determined by a majority of CPET experts among patients with compensated HF. Future studies are needed to investigate the association between VDI and outcomes and whether VDI is superior to EOV in predicting risk in these patients. To facilitate future research, we have provided a template that others can use to calculate VDI.
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